TY  - GEN
AU  - Zhang,Yajing
AU  - Zhang,Wenying
AU  - Dai,Hanren
AU  - Wang,Yao
AU  - Shi,Fengxia
AU  - Wang,Chunmeng
AU  - Guo,Yelei
AU  - Liu,Yang
AU  - Chen,Meixia
AU  - Feng,Kaichao
AU  - Zhang,Yan
AU  - Liu,Chuanjie
AU  - Yang,Qingming
AU  - Li,Suxia
AU  - Han,Weidong
TI  - An analytical biomarker for treatment of patients with recurrent B-ALL after remission induced by infusion of anti-CD19 chimeric antigen receptor T (CAR-T) cells
SN  - 1869-1889
PY  - 2017///0111
KW  - Adult
KW  - Antigens, CD19
KW  - genetics
KW  - Biomarkers, Tumor
KW  - analysis
KW  - C-Reactive Protein
KW  - immunology
KW  - Clinical Trials, Phase I as Topic
KW  - Female
KW  - Humans
KW  - Immunotherapy, Adoptive
KW  - methods
KW  - Interferon-gamma
KW  - blood
KW  - Interleukin-10
KW  - Interleukin-6
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
KW  - Receptors, Antigen, T-Cell
KW  - Recombinant Fusion Proteins
KW  - Remission Induction
KW  - T-Lymphocytes
KW  - Treatment Outcome
N1  - Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s11427-016-5035-4
ER  -